Research Solutions, Inc. (NASDAQ:RSSS) Sees Significant Decrease in Short Interest

Research Solutions, Inc. (NASDAQ:RSSS - Get Free Report) saw a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 19,600 shares, a decrease of 46.6% from the April 30th total of 36,700 shares. Based on an average daily volume of 70,500 shares, the short-interest ratio is presently 0.3 days. Approximately 0.1% of the shares of the stock are sold short.

Research Solutions Stock Down 1.1%

Shares of RSSS traded down $0.03 during trading hours on Friday, reaching $2.77. 14,120 shares of the company traded hands, compared to its average volume of 88,036. The stock has a market capitalization of $89.91 million, a PE ratio of -18.47, a price-to-earnings-growth ratio of 4.33 and a beta of 0.66. Research Solutions has a fifty-two week low of $2.32 and a fifty-two week high of $4.24. The stock has a fifty day simple moving average of $2.70 and a 200 day simple moving average of $3.25.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Heron Bay Capital Management bought a new stake in shares of Research Solutions in the 4th quarter worth approximately $50,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Research Solutions in the fourth quarter valued at approximately $56,000. Schonfeld Strategic Advisors LLC acquired a new stake in shares of Research Solutions in the fourth quarter valued at approximately $62,000. Millennium Management LLC acquired a new stake in Research Solutions in the 4th quarter valued at approximately $65,000. Finally, NewEdge Advisors LLC acquired a new stake in Research Solutions in the 1st quarter valued at approximately $71,000. 33.60% of the stock is owned by institutional investors and hedge funds.

About Research Solutions

Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets.